Glucotrack, Inc. - 8-K Filing

Glucotrack filed an 8-K disclosing Lokahi Therapeutics' significant net loss of $8.1M in Q2 and substantial doubt about its ability to continue as a going concern.

SEC EDGAR ·

Tickers: $GCTK

Read the full article at SEC EDGAR

More Regulatory news